▶ 調査レポート

世界の全身麻酔用医薬品市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global General Anesthesia Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の全身麻酔用医薬品市場 2021:企業別、地域別、種類・用途別 / Global General Anesthesia Medicine Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A14988資料のイメージです。• レポートコード:GIR-107A14988
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、91ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、全身麻酔用医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。全身麻酔用医薬品の種類別市場規模(プロポフォール、エトミデート、ミダゾラム、セボフルラン、イソフルラン、その他)、用途別市場規模(静脈麻酔薬、吸入麻酔薬)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・全身麻酔用医薬品の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Astrazeneca、B.Braun、Fresenius-Kabi、Hikma Pharmaceuticals、Maruishi、Nhwa、Piramal、AbbVie、Baxter Healthcare、Hengrui、Lunan、Mylan
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:プロポフォール、エトミデート、ミダゾラム、セボフルラン、イソフルラン、その他
・用途別分析2016年-2026年:静脈麻酔薬、吸入麻酔薬
・全身麻酔用医薬品の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・全身麻酔用医薬品のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・全身麻酔用医薬品のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・全身麻酔用医薬品の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・全身麻酔用医薬品の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The General Anesthesia Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global General Anesthesia Medicine size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global General Anesthesia Medicine market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
General Anesthesia Medicine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others

Market segment by Application, can be divided into
Intravenous Anesthetics
Inhalational Anesthetics

Market segment by players, this report covers
Astrazeneca
B.Braun
Fresenius-Kabi
Hikma Pharmaceuticals
Maruishi
Nhwa
Piramal
AbbVie
Baxter Healthcare
Hengrui
Lunan
Mylan

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe General Anesthesia Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of General Anesthesia Medicine, with revenue, gross margin and global market share of General Anesthesia Medicine from 2019 to 2021.
Chapter 3, the General Anesthesia Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and General Anesthesia Medicine market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe General Anesthesia Medicine research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of General Anesthesia Medicine
1.2 Classification of General Anesthesia Medicine by Type
1.2.1 Overview: Global General Anesthesia Medicine Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global General Anesthesia Medicine Revenue Market Share by Type in 2020
1.2.3 Propofol
1.2.4 Etomidate
1.2.5 Midazolam
1.2.6 Sevoflurane
1.2.7 Isoflurane
1.2.8 Others
1.3 Global General Anesthesia Medicine Market by Application
1.3.1 Overview: Global General Anesthesia Medicine Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Global General Anesthesia Medicine Market Size & Forecast
1.5 Global General Anesthesia Medicine Market Size and Forecast by Region
1.5.1 Global General Anesthesia Medicine Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global General Anesthesia Medicine Market Size by Region, (2016-2021)
1.5.3 North America General Anesthesia Medicine Market Size and Prospect (2016-2026)
1.5.4 Europe General Anesthesia Medicine Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific General Anesthesia Medicine Market Size and Prospect (2016-2026)
1.5.6 South America General Anesthesia Medicine Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa General Anesthesia Medicine Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 General Anesthesia Medicine Market Drivers
1.6.2 General Anesthesia Medicine Market Restraints
1.6.3 General Anesthesia Medicine Trends Analysis
2 Company Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca General Anesthesia Medicine Product and Solutions
2.1.4 Astrazeneca General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Astrazeneca Recent Developments and Future Plans
2.2 B.Braun
2.2.1 B.Braun Details
2.2.2 B.Braun Major Business
2.2.3 B.Braun General Anesthesia Medicine Product and Solutions
2.2.4 B.Braun General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 B.Braun Recent Developments and Future Plans
2.3 Fresenius-Kabi
2.3.1 Fresenius-Kabi Details
2.3.2 Fresenius-Kabi Major Business
2.3.3 Fresenius-Kabi General Anesthesia Medicine Product and Solutions
2.3.4 Fresenius-Kabi General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Fresenius-Kabi Recent Developments and Future Plans
2.4 Hikma Pharmaceuticals
2.4.1 Hikma Pharmaceuticals Details
2.4.2 Hikma Pharmaceuticals Major Business
2.4.3 Hikma Pharmaceuticals General Anesthesia Medicine Product and Solutions
2.4.4 Hikma Pharmaceuticals General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Hikma Pharmaceuticals Recent Developments and Future Plans
2.5 Maruishi
2.5.1 Maruishi Details
2.5.2 Maruishi Major Business
2.5.3 Maruishi General Anesthesia Medicine Product and Solutions
2.5.4 Maruishi General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Maruishi Recent Developments and Future Plans
2.6 Nhwa
2.6.1 Nhwa Details
2.6.2 Nhwa Major Business
2.6.3 Nhwa General Anesthesia Medicine Product and Solutions
2.6.4 Nhwa General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Nhwa Recent Developments and Future Plans
2.7 Piramal
2.7.1 Piramal Details
2.7.2 Piramal Major Business
2.7.3 Piramal General Anesthesia Medicine Product and Solutions
2.7.4 Piramal General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Piramal Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie General Anesthesia Medicine Product and Solutions
2.8.4 AbbVie General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Baxter Healthcare
2.9.1 Baxter Healthcare Details
2.9.2 Baxter Healthcare Major Business
2.9.3 Baxter Healthcare General Anesthesia Medicine Product and Solutions
2.9.4 Baxter Healthcare General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Baxter Healthcare Recent Developments and Future Plans
2.10 Hengrui
2.10.1 Hengrui Details
2.10.2 Hengrui Major Business
2.10.3 Hengrui General Anesthesia Medicine Product and Solutions
2.10.4 Hengrui General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Hengrui Recent Developments and Future Plans
2.11 Lunan
2.11.1 Lunan Details
2.11.2 Lunan Major Business
2.11.3 Lunan General Anesthesia Medicine Product and Solutions
2.11.4 Lunan General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Lunan Recent Developments and Future Plans
2.12 Mylan
2.12.1 Mylan Details
2.12.2 Mylan Major Business
2.12.3 Mylan General Anesthesia Medicine Product and Solutions
2.12.4 Mylan General Anesthesia Medicine Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Mylan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global General Anesthesia Medicine Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 General Anesthesia Medicine Players Market Share
3.2.2 Top 10 General Anesthesia Medicine Players Market Share
3.2.3 Market Competition Trend
3.3 General Anesthesia Medicine Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global General Anesthesia Medicine Revenue and Market Share by Type (2016-2021)
4.2 Global General Anesthesia Medicine Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global General Anesthesia Medicine Revenue Market Share by Application (2016-2021)
5.2 General Anesthesia Medicine Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America General Anesthesia Medicine Revenue by Type (2016-2026)
6.2 North America General Anesthesia Medicine Revenue by Application (2016-2026)
6.3 North America General Anesthesia Medicine Market Size by Country
6.3.1 North America General Anesthesia Medicine Revenue by Country (2016-2026)
6.3.2 United States General Anesthesia Medicine Market Size and Forecast (2016-2026)
6.3.3 Canada General Anesthesia Medicine Market Size and Forecast (2016-2026)
6.3.4 Mexico General Anesthesia Medicine Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe General Anesthesia Medicine Revenue by Type (2016-2026)
7.2 Europe General Anesthesia Medicine Revenue by Application (2016-2026)
7.3 Europe General Anesthesia Medicine Market Size by Country
7.3.1 Europe General Anesthesia Medicine Revenue by Country (2016-2026)
7.3.2 Germany General Anesthesia Medicine Market Size and Forecast (2016-2026)
7.3.3 France General Anesthesia Medicine Market Size and Forecast (2016-2026)
7.3.4 United Kingdom General Anesthesia Medicine Market Size and Forecast (2016-2026)
7.3.5 Russia General Anesthesia Medicine Market Size and Forecast (2016-2026)
7.3.6 Italy General Anesthesia Medicine Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific General Anesthesia Medicine Revenue by Type (2016-2026)
8.2 Asia-Pacific General Anesthesia Medicine Revenue by Application (2016-2026)
8.3 Asia-Pacific General Anesthesia Medicine Market Size by Region
8.3.1 Asia-Pacific General Anesthesia Medicine Revenue by Region (2016-2026)
8.3.2 China General Anesthesia Medicine Market Size and Forecast (2016-2026)
8.3.3 Japan General Anesthesia Medicine Market Size and Forecast (2016-2026)
8.3.4 South Korea General Anesthesia Medicine Market Size and Forecast (2016-2026)
8.3.5 India General Anesthesia Medicine Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia General Anesthesia Medicine Market Size and Forecast (2016-2026)
8.3.7 Australia General Anesthesia Medicine Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America General Anesthesia Medicine Revenue by Type (2016-2026)
9.2 South America General Anesthesia Medicine Revenue by Application (2016-2026)
9.3 South America General Anesthesia Medicine Market Size by Country
9.3.1 South America General Anesthesia Medicine Revenue by Country (2016-2026)
9.3.2 Brazil General Anesthesia Medicine Market Size and Forecast (2016-2026)
9.3.3 Argentina General Anesthesia Medicine Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa General Anesthesia Medicine Revenue by Type (2016-2026)
10.2 Middle East & Africa General Anesthesia Medicine Revenue by Application (2016-2026)
10.3 Middle East & Africa General Anesthesia Medicine Market Size by Country
10.3.1 Middle East & Africa General Anesthesia Medicine Revenue by Country (2016-2026)
10.3.2 Turkey General Anesthesia Medicine Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia General Anesthesia Medicine Market Size and Forecast (2016-2026)
10.3.4 UAE General Anesthesia Medicine Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global General Anesthesia Medicine Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global General Anesthesia Medicine Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market General Anesthesia Medicine Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global General Anesthesia Medicine Revenue (USD Million) by Region (2016-2021)
Table 5. Global General Anesthesia Medicine Revenue Market Share by Region (2021-2026)
Table 6. Astrazeneca Corporate Information, Head Office, and Major Competitors
Table 7. Astrazeneca Major Business
Table 8. Astrazeneca General Anesthesia Medicine Product and Solutions
Table 9. Astrazeneca General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. B.Braun Corporate Information, Head Office, and Major Competitors
Table 11. B.Braun Major Business
Table 12. B.Braun General Anesthesia Medicine Product and Solutions
Table 13. B.Braun General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Fresenius-Kabi Corporate Information, Head Office, and Major Competitors
Table 15. Fresenius-Kabi Major Business
Table 16. Fresenius-Kabi General Anesthesia Medicine Product and Solutions
Table 17. Fresenius-Kabi General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Hikma Pharmaceuticals Major Business
Table 20. Hikma Pharmaceuticals General Anesthesia Medicine Product and Solutions
Table 21. Hikma Pharmaceuticals General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Maruishi Corporate Information, Head Office, and Major Competitors
Table 23. Maruishi Major Business
Table 24. Maruishi General Anesthesia Medicine Product and Solutions
Table 25. Maruishi General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Nhwa Corporate Information, Head Office, and Major Competitors
Table 27. Nhwa Major Business
Table 28. Nhwa General Anesthesia Medicine Product and Solutions
Table 29. Nhwa General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Piramal Corporate Information, Head Office, and Major Competitors
Table 31. Piramal Major Business
Table 32. Piramal General Anesthesia Medicine Product and Solutions
Table 33. Piramal General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AbbVie Corporate Information, Head Office, and Major Competitors
Table 35. AbbVie Major Business
Table 36. AbbVie General Anesthesia Medicine Product and Solutions
Table 37. AbbVie General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Baxter Healthcare Corporate Information, Head Office, and Major Competitors
Table 39. Baxter Healthcare Major Business
Table 40. Baxter Healthcare General Anesthesia Medicine Product and Solutions
Table 41. Baxter Healthcare General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Hengrui Corporate Information, Head Office, and Major Competitors
Table 43. Hengrui Major Business
Table 44. Hengrui General Anesthesia Medicine Product and Solutions
Table 45. Hengrui General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Lunan Corporate Information, Head Office, and Major Competitors
Table 47. Lunan Major Business
Table 48. Lunan General Anesthesia Medicine Product and Solutions
Table 49. Lunan General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Mylan Corporate Information, Head Office, and Major Competitors
Table 51. Mylan Major Business
Table 52. Mylan General Anesthesia Medicine Product and Solutions
Table 53. Mylan General Anesthesia Medicine Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Global General Anesthesia Medicine Revenue (USD Million) by Players (2019-2021)
Table 55. Global General Anesthesia Medicine Revenue Share by Players (2019-2021)
Table 56. Breakdown of General Anesthesia Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. General Anesthesia Medicine Players Head Office, Products and Services Provided
Table 58. General Anesthesia Medicine Mergers & Acquisitions in the Past Five Years
Table 59. General Anesthesia Medicine New Entrants and Expansion Plans
Table 60. Global General Anesthesia Medicine Revenue (USD Million) by Type (2016-2021)
Table 61. Global General Anesthesia Medicine Revenue Share by Type (2016-2021)
Table 62. Global General Anesthesia Medicine Revenue Forecast by Type (2021-2026)
Table 63. Global General Anesthesia Medicine Revenue by Application (2016-2021)
Table 64. Global General Anesthesia Medicine Revenue Forecast by Application (2021-2026)
Table 65. North America General Anesthesia Medicine Revenue by Type (2016-2021) & (USD Million)
Table 66. North America General Anesthesia Medicine Revenue by Type (2021-2026) & (USD Million)
Table 67. North America General Anesthesia Medicine Revenue by Application (2016-2021) & (USD Million)
Table 68. North America General Anesthesia Medicine Revenue by Application (2021-2026) & (USD Million)
Table 69. North America General Anesthesia Medicine Revenue by Country (2016-2021) & (USD Million)
Table 70. North America General Anesthesia Medicine Revenue by Country (2021-2026) & (USD Million)
Table 71. Europe General Anesthesia Medicine Revenue by Type (2016-2021) & (USD Million)
Table 72. Europe General Anesthesia Medicine Revenue by Type (2021-2026) & (USD Million)
Table 73. Europe General Anesthesia Medicine Revenue by Application (2016-2021) & (USD Million)
Table 74. Europe General Anesthesia Medicine Revenue by Application (2021-2026) & (USD Million)
Table 75. Europe General Anesthesia Medicine Revenue by Country (2016-2021) & (USD Million)
Table 76. Europe General Anesthesia Medicine Revenue by Country (2021-2026) & (USD Million)
Table 77. Asia-Pacific General Anesthesia Medicine Revenue by Type (2016-2021) & (USD Million)
Table 78. Asia-Pacific General Anesthesia Medicine Revenue by Type (2021-2026) & (USD Million)
Table 79. Asia-Pacific General Anesthesia Medicine Revenue by Application (2016-2021) & (USD Million)
Table 80. Asia-Pacific General Anesthesia Medicine Revenue by Application (2021-2026) & (USD Million)
Table 81. Asia-Pacific General Anesthesia Medicine Revenue by Region (2016-2021) & (USD Million)
Table 82. Asia-Pacific General Anesthesia Medicine Revenue by Region (2021-2026) & (USD Million)
Table 83. South America General Anesthesia Medicine Revenue by Type (2016-2021) & (USD Million)
Table 84. South America General Anesthesia Medicine Revenue by Type (2021-2026) & (USD Million)
Table 85. South America General Anesthesia Medicine Revenue by Application (2016-2021) & (USD Million)
Table 86. South America General Anesthesia Medicine Revenue by Application (2021-2026) & (USD Million)
Table 87. South America General Anesthesia Medicine Revenue by Country (2016-2021) & (USD Million)
Table 88. South America General Anesthesia Medicine Revenue by Country (2021-2026) & (USD Million)
Table 89. Middle East & Africa General Anesthesia Medicine Revenue by Type (2016-2021) & (USD Million)
Table 90. Middle East & Africa General Anesthesia Medicine Revenue by Type (2021-2026) & (USD Million)
Table 91. Middle East & Africa General Anesthesia Medicine Revenue by Application (2016-2021) & (USD Million)
Table 92. Middle East & Africa General Anesthesia Medicine Revenue by Application (2021-2026) & (USD Million)
Table 93. Middle East & Africa General Anesthesia Medicine Revenue by Country (2016-2021) & (USD Million)
Table 94. Middle East & Africa General Anesthesia Medicine Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. General Anesthesia Medicine Picture
Figure 2. Global General Anesthesia Medicine Revenue Market Share by Type in 2020
Figure 3. Propofol
Figure 4. Etomidate
Figure 5. Midazolam
Figure 6. Sevoflurane
Figure 7. Isoflurane
Figure 8. Others
Figure 9. General Anesthesia Medicine Revenue Market Share by Application in 2020
Figure 10. Intravenous Anesthetics Picture
Figure 11. Inhalational Anesthetics Picture
Figure 12. Global General Anesthesia Medicine Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global General Anesthesia Medicine Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global General Anesthesia Medicine Revenue Market Share by Region (2016-2026)
Figure 15. Global General Anesthesia Medicine Revenue Market Share by Region in 2020
Figure 16. North America General Anesthesia Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe General Anesthesia Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific General Anesthesia Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America General Anesthesia Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa General Anesthesia Medicine Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. General Anesthesia Medicine Market Drivers
Figure 22. General Anesthesia Medicine Market Restraints
Figure 23. General Anesthesia Medicine Market Trends
Figure 24. Astrazeneca Recent Developments and Future Plans
Figure 25. B.Braun Recent Developments and Future Plans
Figure 26. Fresenius-Kabi Recent Developments and Future Plans
Figure 27. Hikma Pharmaceuticals Recent Developments and Future Plans
Figure 28. Maruishi Recent Developments and Future Plans
Figure 29. Nhwa Recent Developments and Future Plans
Figure 30. Piramal Recent Developments and Future Plans
Figure 31. AbbVie Recent Developments and Future Plans
Figure 32. Baxter Healthcare Recent Developments and Future Plans
Figure 33. Hengrui Recent Developments and Future Plans
Figure 34. Lunan Recent Developments and Future Plans
Figure 35. Mylan Recent Developments and Future Plans
Figure 36. Global General Anesthesia Medicine Revenue Share by Players in 2020
Figure 37. General Anesthesia Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 38. Global Top 3 Players General Anesthesia Medicine Revenue Market Share in 2020
Figure 39. Global Top 10 Players General Anesthesia Medicine Revenue Market Share in 2020
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 41. Global General Anesthesia Medicine Revenue Share by Type in 2020
Figure 42. Global General Anesthesia Medicine Market Share Forecast by Type (2021-2026)
Figure 43. Global General Anesthesia Medicine Revenue Share by Application in 2020
Figure 44. Global General Anesthesia Medicine Market Share Forecast by Application (2021-2026)
Figure 45. North America General Anesthesia Medicine Sales Market Share by Type (2016-2026)
Figure 46. North America General Anesthesia Medicine Sales Market Share by Application (2016-2026)
Figure 47. North America General Anesthesia Medicine Revenue Market Share by Country (2016-2026)
Figure 48. United States General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Canada General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Mexico General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Europe General Anesthesia Medicine Sales Market Share by Type (2016-2026)
Figure 52. Europe General Anesthesia Medicine Sales Market Share by Application (2016-2026)
Figure 53. Europe General Anesthesia Medicine Revenue Market Share by Country (2016-2026)
Figure 54. Germany General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific General Anesthesia Medicine Sales Market Share by Type (2016-2026)
Figure 60. Asia-Pacific General Anesthesia Medicine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific General Anesthesia Medicine Revenue Market Share by Region (2016-2026)
Figure 62. China General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Japan General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South Korea General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. India General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Southeast Asia General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Australia General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. South America General Anesthesia Medicine Sales Market Share by Type (2016-2026)
Figure 69. South America General Anesthesia Medicine Sales Market Share by Application (2016-2026)
Figure 70. South America General Anesthesia Medicine Revenue Market Share by Country (2016-2026)
Figure 71. Brazil General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Argentina General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Middle East and Africa General Anesthesia Medicine Sales Market Share by Type (2016-2026)
Figure 74. Middle East and Africa General Anesthesia Medicine Sales Market Share by Application (2016-2026)
Figure 75. Middle East and Africa General Anesthesia Medicine Revenue Market Share by Country (2016-2026)
Figure 76. Turkey General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. UAE General Anesthesia Medicine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source